Results of a double‐blind sham‐controlled trial examining the effects of hyperbaric oxygen therapy on cognition and brain biomarkers
HBOT did not improve cognitive or brain imaging outcomes compared to sham in older adults with T2D and MCI. A transient cognitive benefit was observed in the sham group immediately post-intervention. The higher rate of SAEs in the HBOT group for this population with high comorbidities warrants further investigation.
Authors
- Ganit Almog
- Maayan Harel (ORCID: https://orcid.org/0000-0002-1386-8656)
- Amir Hadanny (ORCID: https://orcid.org/0000-0001-9028-7268)
- Livny Abigail
- Y. Mardor
- Liangyuan Hu (ORCID: https://orcid.org/0000-0002-4067-892X)
- Roy Sagi
- Orit H. Lesman‐Segev (ORCID: https://orcid.org/0000-0002-6273-7142)
- Lan Luo (ORCID: https://orcid.org/0000-0001-8189-4162)
- Mary Sano
- Ori Benari
- Barbara B. Bendlin
- Michal Schnaider Beeri
- Sapir Golan
- Ramit Ravona‐Springer
- Shai Efrati
Institutions
- Rutgers, The State University of New Jersey (US)
- University of Wisconsin–Madison (US)
- Bar-Ilan University (IL)
- Tel Aviv University (IL)
- Sheba Medical Center (IL)
- Assaf Harofeh Medical Center (IL)
- Icahn School of Medicine at Mount Sinai (US)
Publication Details
- Journal
- Alzheimer s & Dementia
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1002/alz70861_108814
- Primary Topic
- Diabetic Foot Ulcer Assessment and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00